Key Takeaways
- • Chicago-based Svoboda Capital Partners has agreed to terms on a financial partnership with 120/80 Health Group, a New York firm providing communications, marketing and strategy programs to healthcare and life sciences companies.
- • 120/80, founded in 2018, combines strategic advice, media, content, marketing, corporate communications and analytics for clients ranging from pre-Series A startups to public companies.
- • Capital will fund reinvestment in the team and clients and an expansion of talent and services; the deal's size was not disclosed in the source material.
- • Svoboda managing director Will King said the firm intends to preserve 120/80's culture while providing capital and support for growth.
Summary
The capital will fund reinvestment in 120/80's team and client work, along with an expansion of its talent and services. Rob Cronin, chief executive of 120/80, said the partnership will help build a platform serving innovators in healthcare and life sciences.
Chicago-based Svoboda has previously backed other strategic communications firms. Will King, a managing director at Svoboda, said the firm aims to preserve the culture of 120/80 while providing capital and support for its growth.
The source material does not disclose the investment size, ownership stake or other financial terms of the transaction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.